What Is GHK-Cu? The Copper Peptide, and What the Human Trials Actually Found
GHK-Cu has 179 published papers and, unusually, randomised human trials. Both were topical, and neither showed an objective benefit.
Educational, research-only overviews of peptides, blends, testing methods, and how to read the scientific literature. For laboratory and research use only.
GHK-Cu has 179 published papers and, unusually, randomised human trials. Both were topical, and neither showed an objective benefit.
The Wolverine stack is a nickname for combining BPC-157 and TB-500. The one study that tested the combination found it conferred no additional benefit over either
GLOW is a three-peptide research blend of GHK-Cu, BPC-157 and TB-500, totalling 70 mg per vial. What is in it, what the literature examines for each
BPC-157 survives gastric acid, but that is not the same as being absorbed. The bioavailability figures in circulation are intramuscular, from rats and dogs. What the
TB-500 is the supplier name for a peptide based on thymosin beta-4, an actin-binding protein. What the published Tβ4 research examines, why the two names are
Thymosin alpha-1 is a 28-amino-acid peptide produced by the thymus, studied mainly for immune modulation. What it is, what the literature examines, and what it does
Weekly peptide research summaries, testing guides, and documentation updates.
Semax is a synthetic heptapeptide derived from ACTH, developed in Russia. What it is, why it has no hormonal activity, what the neurotrophin research examines, and
5-Amino-1MQ is a small-molecule NNMT inhibitor, not a peptide. What it is, how large its literature actually is, what the NNMT research examines, and what none
Selank is a synthetic heptapeptide analog of tuftsin developed in Russia. What it is, what the published research examines, why nearly all of that research is
Discount Applied Successfully!
Your savings have been added to the cart.